Healthcare Partnerships Strong traction with hospitals and health networks (e.g., Scarborough Health Network and Kaiser Permanente Dublin) indicates a sales opportunity to expand into hospital sterile processing, patient care environments, and infection control programs that require chemical-free sanitization for devices.

Device Hygiene Market Customer focus on sanitizing mobile devices and high-touch equipment presents a path to target healthcare facilities, hotels, and other high-sensitivity sectors with UV-C sanitization solutions that preserve device integrity while reducing microbial risk.

Public Funding Momentum Historical funding activity including a $7M round and early-stage investments signals ongoing investor interest; leverage this narrative to engage with regional economic development groups, grant programs, and potential strategic investors to accelerate product adoption.

Healthcare Compliance Fit Partnerships with large health systems imply a need for regulated, auditable sanitization workflows; position solutions as compliant, repeatable, and easily integrated into sterilization departments to win similar hospital and clinic contracts.

Scalable Product Rollout Recent product introductions like Versa and collaborations to visualize UV-C efficacy offer a roadmap for pilots and staged deployments; target multi-site facilities, chains, and corporate wellness programs seeking standardized sanitization across locations.